电脑辅助检测（CAD）全球市场规模、份额、趋势和成长分析报告（2026-2034）

电脑辅助侦测 (CAD) 市场预计将从 2025 年的 10.9 亿美元成长到 2034 年的 25.3 亿美元，2026 年至 2034 年的复合年增长率为 9.84%。

全球电脑辅助检测 (CAD) 市场随着数位成像技术的进步而发展。 CAD 系统透过突出显示放射影像影像检查（尤其是乳房 X 光检查和肺部影像）中的潜在异常情况来辅助医疗专业人员。向数位成像平台的转变正在加速医院和诊断检查室对 CAD 的应用。

关键成长要素包括癌症和其他慢性疾病盛行率的上升、筛检项目的扩展以及对第二意见诊断工具日益增长的需求。深度学习和影像处理技术的进步提高了检测精度。与现有成像系统的整合简化了工作流程，促使医疗机构投资于电脑辅助诊断 (CAD) 解决方案。

未来的成长取决于持续的技术创新和临床检验，以证明其能够改善患者预后。将应用范围从传统成像扩展到多重模式诊断将创造新的机会。随着医疗机构更加重视早期检测和提高效率，电脑辅助诊断（CAD）系统预计仍将是诊断影像中不可或缺的工具。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球电脑辅助侦测（CAD）市场：按应用领域划分

• 市场分析、洞察与预测
• 乳癌
• 肺癌
• 大肠直肠癌/直肠癌
• 摄护腺癌
• 肝癌
• 骨癌
• 神经系统、肌肉骨骼系统与心血管系统的癌症

第五章：全球电脑辅助侦测（CAD）市场：依乳房CAD影像方法划分

• 市场分析、洞察与预测
• 乳房X光检查
• 磁振造影
• 超音波影像
• 断层合成
• 核子医学扫描术诊断

第六章：全球电脑辅助侦测（CAD）市场：依诊断影像方法划分

• 市场分析、洞察与预测
• X光影像诊断
• 电脑断层扫描
• 超音波影像
• 磁振造影
• 核医学影像

第七章 全球电脑辅助侦测（CAD）市场：依最终使用者划分

• 市场分析、洞察与预测
• 医院
• 诊断中心
• 研究中心

第八章 全球电脑辅助侦测（CAD）市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Hologic Inc
  • ICAD Inc
  • GE HealthCare
  • Siemens Healthineers AG
  • Agfa-Gevaert Group
  • Koninklijke Philips NV
  • Canon Medical Systems Corporation
  • Fujifilm Corporation
  • EDDA Technology Inc
  • Riverain Technologies
  • Therapixel
  • ScreenPoint Medical BV
  • Zebra Medical Vision Ltd
  • Qlarity Imaging LLC
  • Median Technologies

The Computer Aided Detection Market size is expected to reach USD 2.53 Billion in 2034 from USD 1.09 Billion (2025) growing at a CAGR of 9.84% during 2026-2034.

The global computer aided detection (CAD) market has evolved alongside advancements in digital imaging technologies. CAD systems assist healthcare professionals by highlighting potential abnormalities in radiology scans, particularly in mammography and lung imaging. The transition to digital imaging platforms has strengthened CAD adoption across hospitals and diagnostic laboratories.

Key drivers include the increasing prevalence of cancer and other chronic diseases, rising screening programs, and growing demand for second-opinion diagnostic tools. Technological improvements in deep learning and image processing have enhanced detection accuracy. Integration with existing imaging systems ensures smoother workflow implementation, encouraging healthcare providers to invest in CAD solutions.

Future growth will depend on continued innovation and clinical validation demonstrating improved patient outcomes. Expanding applications beyond traditional imaging into multi-modality diagnostics will create new opportunities. As healthcare providers focus on early detection and efficiency, CAD systems are expected to remain an essential tool in diagnostic imaging.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Breast Cancer
• Lung Cancer
• Colon/Rectal Cancer
• Prostate Cancer
• Liver Cancer
• Bone Cancer
• Neurological/Musculoskeletal/Cardiovascular Cancer

By Breast CAD Imaging Modalities

• Mammography
• Magnetic Resonance Imaging
• Ultrasound Imaging
• Tomosynthesis
• Nuclear Imaging

By Imaging Modalities

• X-Ray Imaging
• Computed Tomography
• Ultrasound Imaging
• Magnetic Resonance
• Nuclear Medicine Imaging

By End User

• Hospitals
• Diagnostic Centers
• Research Centers

COMPANIES PROFILED

• Hologic Inc, iCAD Inc, GE HealthCare, Siemens Healthineers AG, AgfaGevaert Group, Koninklijke Philips NV, Canon Medical Systems Corporation, Fujifilm Corporation, EDDA Technology Inc, Riverain Technologies, Therapixel, ScreenPoint Medical BV, Zebra Medical Vision Ltd, Qlarity Imaging LLC, Median Technologies
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COMPUTER AIDED DETECTION MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Colon/Rectal Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Liver Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Bone Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Neurological/Musculoskeletal/Cardiovascular Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COMPUTER AIDED DETECTION MARKET: BY BREAST CAD IMAGING MODALITIES 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Breast Cad Imaging Modalities
• 5.2. Mammography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Magnetic Resonance Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Ultrasound Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Tomosynthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Nuclear Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COMPUTER AIDED DETECTION MARKET: BY IMAGING MODALITIES 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Imaging Modalities
• 6.2. X-Ray Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Computed Tomography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ultrasound Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Magnetic Resonance Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Nuclear Medicine Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COMPUTER AIDED DETECTION MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL COMPUTER AIDED DETECTION MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Application
  • 8.2.2 By Breast Cad Imaging Modalities
  • 8.2.3 By Imaging Modalities
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Application
  • 8.3.2 By Breast Cad Imaging Modalities
  • 8.3.3 By Imaging Modalities
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Application
  • 8.4.2 By Breast Cad Imaging Modalities
  • 8.4.3 By Imaging Modalities
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Application
  • 8.5.2 By Breast Cad Imaging Modalities
  • 8.5.3 By Imaging Modalities
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Application
  • 8.6.2 By Breast Cad Imaging Modalities
  • 8.6.3 By Imaging Modalities
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL COMPUTER AIDED DETECTION INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Hologic Inc
  • 10.2.2 ICAD Inc
  • 10.2.3 GE HealthCare
  • 10.2.4 Siemens Healthineers AG
  • 10.2.5 Agfa-Gevaert Group
  • 10.2.6 Koninklijke Philips N.V
  • 10.2.7 Canon Medical Systems Corporation
  • 10.2.8 Fujifilm Corporation
  • 10.2.9 EDDA Technology Inc
  • 10.2.10 Riverain Technologies
  • 10.2.11 Therapixel
  • 10.2.12 ScreenPoint Medical B.V
  • 10.2.13 Zebra Medical Vision Ltd
  • 10.2.14 Qlarity Imaging LLC
  • 10.2.15 Median Technologies